Sign in

Jesús F. Bermejo-Martin

@biosepsis.bsky.social
1.9K followers 2.6K following 150 posts

MD PhD Professor, Medicine Dept, Universidad de Salamanca (USAL). Principal Investigator, BioSepsis (Translational Research in Severe Infections) - IBSAL / USAL / CIBERES / EGIS #IDsky 🇪🇦🇪🇺

PostsRepliesMedia
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 17/09/2026
Acabo de recibir una excelente noticia, la acreditación a Prof. Titular de Universidad por la ANECA! Aunque vengo del mundo de la investigación en hospitales (20 años), siempre he compatibilizado esta labor con la docencia universitaria (director de tesis, tutor de residentes, PRAS), un pasito más!
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 13/09/2026
011
Reposted by Jesús F. Bermejo-Martin
Hannibal Lecter 🦋 @hannibal.bsky.social · 05/09/2026
Este vídeo de Óscar Camps, el fundador de Open Arms, merece la pena ser visionado.
7921651547
Reposted by Jesús F. Bermejo-Martin
Andre Kalil, MD MPH @drandrekalil.bsky.social · 29/08/2026
💥🆕“Hospital Strategies to Improve Sepsis Outcomes” IDSA/ACEP/ASM/PIDS/SCCM/SHEA/SHM/SIDP 👇Free bit.ly/3UnauhT @unmc-id.bsky.social @critcaremed.bsky.social @criticalcarereviews.com #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #ClinMicro @cidjournal.bsky.social @cmicomms.bsky.social
bit.ly
IDSA/ACEP/ASM/PIDS/SCCM/SHEA/SHM/SIDP Multisociety Position Paper: Hospital Strategies to Improve Sepsis Outcomes
Abstract. Sepsis remains a leading cause of morbidity and mortality in US hospitals despite extensive efforts to improve early recognition and treatment, p
0116
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 25/08/2026
The EU must support Canada, working together with UK also to promote free commerce, culture and science, and to protect together democracy and the free world.
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 10/08/2026
Just published! The editorial in Chest with my good friend Profesor Toni Torres on eosinophil counts in community-acquired pneumonia is out! #IDsky #pneumonia Predicting Outcomes in Community-Acquired Pneumonia - CHEST journal.chestnet.org/article/S001...
journal.chestnet.org
Predicting Outcomes in Community-Acquired Pneumonia
Eosinophils are granulocytes that play a significant role in fighting infections caused by parasites. They also participate in the pathogenesis of allergic diseases. But there is increasing evidence a...
011
Reposted by Jesús F. Bermejo-Martin
Antonio Guerrero MD PhD @guerreroespejo.bsky.social · 24/06/2026
The European Association of Urology guidelines recommend consideration of #UTI #vaccines. This vaccine has been available worldwide for over a decade. #IDSky #UTISky
042
Reposted by Jesús F. Bermejo-Martin
Andy Conway Morris @andymoz78.bsky.social · 23/06/2026
Great to see our new paper out in Nature Communications. In it we describe three novel phenotypes in lungs of patients with pneumonia. Pn1 -a non-neutrophil driven lung injury phenotype, Pn2-a balanced immune response with best recovery and Pn3-persistent inflammation driven by immature neutrophils
rdcu.be
Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes
Nature Communications - Analysis of cell samples from pneumonia patients may indicate specific phenotypes associated with disease. Here the authors use a multi-omics approach to analyse...
2189
Reposted by Jesús F. Bermejo-Martin
josh farkas 💊 @pulmcrit.bsky.social · 21/06/2026
Is oseltamivir killing ICU patients? The p-value for these results is NOT significant by traditional Frequentist benchmarks (p>0.05). But Bayesian statistics yield strongly positive results! Where does the truth lie? See what you think. Fresh blog: emcrit.org/pulmcrit/rem...
151
Reposted by Jesús F. Bermejo-Martin
CIDRAP @cidrap.bsky.social · 12/06/2026
Remote monitoring of sepsis patients does not reduce hospital readmissions. Various at-home surveillance methods for patients with severe infections do not prevent them from returning to the hospital, a new study finds. Read more: ow.ly/6jNH50ZbjV1
Sepsis concept photo: Wooden blocks spelling 'SEPSIS' surrounded by a stethoscope, spray, syringe, and blister pack of capsules on a blue surface.
1206
Reposted by Jesús F. Bermejo-Martin
Jesús Rodríguez Baño @jesusrbano.bsky.social · 30/05/2026
Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee @cmijournal.bsky.social @escmid.bsky.social www.clinicalmicrobiologyandinfection.org/article/S119...
clinicalmicrobiologyandinfection.org
Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee
The ongoing outbreak of Ebola virus disease (EVD) caused by Bundibugyo ebolavirus (BDBV) in the Democratic Republic of the Congo (DRC) and Uganda represents a major regional public health emergency wi...
1108
Reposted by Jesús F. Bermejo-Martin
Jesús Rodríguez Baño @jesusrbano.bsky.social · 30/05/2026
First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib @cmijournal.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
022
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 23/05/2026
The final version of our article evidencing that critically ill COVID-19 patients developing an early respiratory failure have live virus in the lung and high viral loads has been published today #IDsky www.sciencedirect.com/science/arti...
sciencedirect.com
Poor control of pulmonary viral replication in COVID-19 patients with early respiratory failure
Severe respiratory failure is the leading cause of intensive care unit (ICU) admission and mortality in critically ill COVID-19 patients. However, whe…
010
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 22/05/2026
The Ebola outbreak brings to my mind this letter we published in Lancet Global Health proposing serum from vaccinated individuals as treatment (not appliable to the present epidemy since there is no vaccine yet, but some candidates are under research) #IDsky www.sciencedirect.com/science/arti...
sciencedirect.com
Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease?
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 17/05/2026
www.bbc.com/news/article...
bbc.com
How worrying is the Ebola outbreak in DR Congo?
An outbreak in DR Congo has been declared a health emergency, with almost 250 suspected cases reported.
000
Reposted by Jesús F. Bermejo-Martin
Juan E. Losa @juanelosag.bsky.social · 15/05/2026
La carga viral en la infección por el virus de los Andes es mayor que en otras infecciones por hantavirus. En esta infección existe una correlación inversa de la respuesta sérica de IgG específica con la carga viral y con la gravedad de la infección.
111
Reposted by Jesús F. Bermejo-Martin
Juan E. Losa @juanelosag.bsky.social · 15/05/2026
Estas son las conclusiones de este interesantísimo estudio publicado hace 11 años, y que podría tener utilidad clínica en el brote actual. onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
011
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 10/05/2026
¿Por qué los ancianos tuvieron una mayor mortalidad durante el primer año de la pandemia por COVID-19? En este articulo liderado por Tamara Postigo describimos signos de una respuesta antiviral deficiente, con activación de la coagulación y más daño endotelial. link.springer.com/article/10.1...
link.springer.com
Key factors of the deranged antiviral response in elderly patients with COVID-19: a machine-learning analysis - GeroScience
Age is a well-known risk factor to develop severe viral respiratory infections, including severe COVID-19. This study aimed to identify the biological alterations linked to severe disease in elderly p...
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 06/05/2026
Why did the elderly suffer higher morbidity and mortality during the first year of the pandemic? This new multicenter study, coordinated by our group @BioSepsis, provides key insights. Congrats to Tamara Postigo for her leadership with this. link.springer.com/article/10.1...
link.springer.com
Key factors of the deranged antiviral response in elderly patients with COVID-19: a machine-learning analysis - GeroScience
Age is a well-known risk factor to develop severe viral respiratory infections, including severe COVID-19. This study aimed to identify the biological alterations linked to severe disease in elderly p...
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 12/04/2026
Today I share a visual abstract of one of the articles I like the most from our group, deciphering key immunopathological events in severe pandemic influenza. This was a colaboration with my former boss, Dr. David Kelvin, and it was published in Critical Care in 2010: doi: 10.1186/cc9259 #IDsky
020
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 08/04/2026
In this visual abstract of our article in In IJID we highlight the importance of of combining innate immunity and endothelial dysfunction biomarkers to predict increases in the magnitude of organ failure in patients with infection and sepsis (10.1016/j.ijid.2024.107142)
220
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 06/04/2026
Another visual abstract of a previous work from our group evidencing the benefit of implementing programms to detect sepsis in preventing mortality derived from nosocomial sepsis (J Hosp Infec DOI: 10.1016/j.jhin.2017.08.022) #IDsky #sepsis
010
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 05/04/2026
I share here the visual abstract of an important article from our group in colab with the groups of Dr Toni Torres (Hospital Clinic) and Rosario Menendez (Hosp La Fe) identifying Lymphopenic Community Acquired Pneumonia as a phenotype associated with mortality doi: 10.1016/j.ebiom.2017.09.023 #IDsky
130
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 03/04/2026
This article from our group summarised the main immunological alterations in sepsis (Journal of Infection doi: 10.1016/j.jinf.2016.01.010) www.journalofinfection.com/article/S016...
121
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 02/04/2026
A new summary of an old article from our group published in Journal of Infection (doi: 10.1016/j.jinf.2014.12.010) #sepsis #IDsky #infection
111
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 31/03/2026
With the support of AI, I am starting to summarise some of our more important articles (summary 1: Quantification of Immune Dysregulation by Next-generation Polymerase Chain Reaction to Improve Sepsis Diagnosis in Surgical Patients", Annals of Surgery, DOI: 10.1097/SLA.0000000000002406)
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 29/03/2026
In the pandemics, a mainstream theory proposed that in critical status, viral replication was over. Here we show that 60% of ventilated patients had replicative virus in the lungs, with 20% in high levels, mainly those with early resp. failure. #IDsky #COVID19 www.sciencedirect.com/science/arti...
sciencedirect.com
Poor control of pulmonary viral replication in COVID-19 patients with early respiratory failure
Severe respiratory failure is the leading cause of intensive care unit (ICU) admission and mortality in critically ill COVID-19 patients. However, whe…
052
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 17/03/2026
Do critically ill COVID-19 patients still carry live virus in the lungs? In our new study we show that patients who develop rapid respiratory failure still have replicating virus. Important finding for guiding antivirals in future pandemics #IDsky #COVID19 www.sciencedirect.com/science/arti...
sciencedirect.com
Poor control of pulmonary viral replication in COVID-19 patients with early respiratory failure
Severe respiratory failure is the leading cause of intensive care unit (ICU) admission and mortality in critically ill COVID-19 patients. However, whe…
000
Reposted by Jesús F. Bermejo-Martin
Andre Kalil, MD MPH @drandrekalil.bsky.social · 27/02/2026
💥🆕“Sepsis”.The Lancet Seminar Our new article 👇Free Access bit.ly/4aJIiKo @unmc.bsky.social @unmc-id.bsky.social @unmccom.bsky.social @critcaremed.bsky.social @criticalcarereviews.com @thelancet.com @thelancetinfdis.bsky.social@lancetrespirmed.bsky.social#IDSky #MedSky #PCCSky #ICUSky #Ansky #EMSky
bit.ly
Sepsis
Sepsis is defined as a dysregulated host response to infection that leads to life-threatening organ dysfunction. The infectious insult triggers a dysr…
0125
Reposted by Jesús F. Bermejo-Martin
Ruth Ann Crystal @drruth.bsky.social · 14/02/2026
In immunocompromised patients, persistent COVID often fails single-drug treatment. Madrid study shows combination therapy (Remdesivir + Paxlovid ± Sotrovimab) clears infection and overcomes resistance. buff.ly/tqlmc0I Personalized antiviral strategies matter. #medsky #IDsky #publichealth #oncsky
Infographic on Madrid study. For immunocompromised, need combination antivirals +/- monoclonal antibodies to get rid of persistent COVID infection in immunocompromised. Blue title. Red single drug box. Green combination box. Bottles of Remdesivir, Paxlovid, syringe of Sotrovimab. COVID virus breaks up with combo drugs.
25620
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 14/02/2026
A new paper from WHO-ISARIC that confirms lymphopenia as a marker of severity and poor prognosis in COVID-19, reinforcing our description of lymphopenic CAP (L-CAP) in 2017 In EbioMedine (I link our paper as a response to this one) link.springer.com/article/10.1...
link.springer.com
Immune dysregulation through longitudinal lymphocyte trajectories and their clinical determinants in hospitalized COVID-19 patients - Intensive Care Medicine Experimental
Objective Immune dysregulation plays a pivotal role in the pathophysiology of sepsis and COVID-19, with lymphopenia emerging as a consistent marker of severity and poor prognosis. However, most existi...
210
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 11/02/2026
This paper identifies transcriptomic signatures associated to mortality in sepsis similar to those we found ten years ago: neutrophil dysregulation + adaptive immunity depression, and evidences the relevance of combining host and microbial info. academic.oup.com/ajrccm/artic...
academic.oup.com
Host–Microbe Multiomic Profiling Predicts Mortality in Sepsis
Abstract. Rationale: Sepsis is a leading cause of mortality and involves a dysregulated host response to infection. The host and microbe have historically
100
Reposted by Jesús F. Bermejo-Martin
ATS Blue Journal @atsblueeditor.bsky.social · 11/02/2026
Microbes Meet Host: The Next Frontier in Sepsis Classification @atscommunity.bsky.social #medsky 🔓 Open Access 🔗 tinyurl.com/bdes2e5s
tinyurl.com
Microbes Meet Host: The Next Frontier in Sepsis Classification
Our pathophysiological understanding of human disease fundamentally relies on our ability to make reproducible observations that demonstrate consistency an
011
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 26/01/2026
After more than eight years serving as coordinator of the European Group on Immunology of Sepsis (EGIS) along with Prof. Ignacio Rubio, it is time for me to step back. The steering committee has designed Dr. Martin Winkler as my sucessor. I am sure he will do an excellent job. www.egis-online.eu
egis-online.eu
the European Group on Immunology of Sepsis
011
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 21/01/2026
News are so terrible these days, that I need to concentrate in something constructive: let's do science, teach and cure people working together! In the world we are more people willing to improve things than those willing to destroy it...!
010
Reposted by Jesús F. Bermejo-Martin
Lawrence Lynn @lawrencelynn.bsky.social · 06/01/2026
@biosepsis.bsky.social Help raise awareness of the patient safety need for critical care clinical trial reform by forwarding this review. pssjournal.biomedcentral.com/articles/10....
pssjournal.biomedcentral.com
Flawed design and selection bias in critical care randomized controlled trials (RCTs): the patient safety risk of the “RCT mimic” - Patient Safety in Surgery
Over three decades, randomized controlled trials (RCTs) for critical care syndromes such as acute respiratory distress syndrome (ARDS), sepsis, and community acquired pneumonia (CAP) have repeatedly p...
011
Reposted by Jesús F. Bermejo-Martin
Jesse Eisinger @jeisinger.bsky.social · 20/12/2025
Excellent piece that explains why Denmark’s childhood vaccine schedule isn’t right for the United States. Every major publication should run a piece like this. @jakescottmd.bsky.social: www.statnews.com/2025/12/19/d...
statnews.com
Why Denmark's vaccine schedule works for Denmark — but not for the United States
With its vaccine schedule, “Denmark has made a values choice to accept preventable hospitalizations and illnesses that other countries have chosen to prevent.”
35223
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 14/12/2025
Terrible attacks against the Jewish community in Australia and against the University community in the USA this week. My sincere condolences to the victims and their families.
020
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 09/12/2025
This (just published) paper confirms what we described in 2021: critically ill COVID-19 patients lacking of antibodies against the virus have poorer outcomes. I link the two papers below.. link.springer.com/article/10.1...
link.springer.com
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study - Intensive Care Medicine Experimental
Background Despite advances in treatment, critically ill COVID-19 patients requiring intensive care unit (ICU) admission continue to comprise a substantial proportion of cases. However, the factors in...
110
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 08/12/2025
With 450 million people, some of the best Universities in the world, the more advanced democratic systems and the best social protection in the world, we should believe in our own future...we the European Union countries must stay together to keep on representing a model to the world! #EuropeanUnion
010
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 26/11/2025
New vignette on our Editorial published in Intensive Care Medicine, written by Dr Jean-Marc Cavaillon, Dr Hjalmar Bouma and myself! #IDsky link.springer.com/article/10.1...
020
Reposted by Jesús F. Bermejo-Martin
Nico Dauby MD PhD @infectiobxl.bsky.social · 23/11/2025
A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trial #IDSky www.thelancet.com/journals/lan...
thelancet.com
A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a...
The clinical decision tool reduced antibiotic prescribing in children without causing harm. Our results support its broader dissemination and implementation to improve the management of acutely ill ch...
051
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 22/11/2025
Our editorial on the clinical value and physiological meaning of HLA-DR in monocytes in septic shock is out. In this editorial we comment on an article from Dr. Monneret et al on a large cohort. It has been a honor to write it with Dr Cavaillon and Dr Bouma #IDsky link.springer.com/article/10.1...
link.springer.com
Thirty years of mHLA-DR research in septic shock: lessons and caveats for clinical translation - Intensive Care Medicine
Intensive Care Medicine -
000
Reposted by Jesús F. Bermejo-Martin
Otavio Ranzani @otavioranzani.bsky.social · 09/11/2025
🚨 The Interim Report of the Global Climate and Health Summit is out! Please, read, share and connect with us. The second phase is open Honoured to be a Vice-Chair of this Summit www.physoc.org/policy/clima...
physoc.org
Global Climate and Health Summit
The 2025 Global Climate and Health Summit placed physiology and partnerships at the heart of climate and health. Read more
072
Reposted by Jesús F. Bermejo-Martin
Marc Veldhoen @marcveld.bsky.social · 05/11/2025
The immune system is dangerous, usually more to pathogens than to you. But only because it’s so tightly controlled. Activating a T cell can have horrific consequences. You really don’t want to trigger one unless it’s absolutely necessary. You need to be sure. How? 1/10
36519
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 04/10/2025
Top speakers, new projects with our European Group on Immunology of Sepsis (EGIS)...the Sepsis Update meeting in Heilderberg finish but we are back home with much work ahead! Thanks for inviting me again to participate! Sepsis is not a single disease, but different ones... sepsis-update.de
sepsis-update.de
Home - Sepsis-Update 2025 DSG
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 23/09/2025
For fifth consecutive year, I appear in the 'Stanford list' of the most cited researchers in the world...Thanks to my group and our collaborators.... elsevier.digitalcommonsdata.com/datasets/btc...
elsevier.digitalcommonsdata.com
August 2025 data-update for "Updated science-wide author databases of standardized citation indicators"
Citation metrics are widely used and misused. We have created a publicly available database of top-cited scientists that provides standardized information on citations, h-index, co-authorship adjusted...
010
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 21/09/2025
An honor to have participated in the International Board of the XXI Congress of the European Shock Society. Congratulations to Borna Relja for an excellent scientific program and the perfect organization.Top speakers & an intense scientific exchange. The abstracs are available in the journal Shock.
journals.lww.com
September 2025 - Volume 64 - Issue 3S : Shock
000
Jesús F. Bermejo-Martin @biosepsis.bsky.social · 20/09/2025
Fantastic meeting of the European Shock Society at Dubrovnick, where I presented our work on proteomics associated to AI to stratify infection severity europeanshocksociety.org/Welcome---21...
europeanshocksociety.org
Welcome - 21st Congress of the European Shock Society, September 18-21, 2025 - European Shock Society
000
Reposted by Jesús F. Bermejo-Martin
Juan E. Losa @juanelosag.bsky.social · 18/09/2025
Importante resultado del primer ensayo clínico aleatorizado y doble ciego de tratamiento antiviral en pacientes inmunodeprimidos. En un subgrupo de 57 pacientes con inmunosupresión de alto riesgo (sigue)
thelancet.com
111